Incidentally detected splenic lesions in ultrasound: does contrast-enhanced ultrasonography improve the differentiation of benign hemangioma/hamartoma from malignant lesions?

PURPOSE

The aim of the study was to identify and validate enhancing features for differentiating benign vascular neoplasms of the hemangioma/hamartoma type from malignant splenic lesions on contrast-enhanced ultrasonography (CEUS).

MATERIALS AND METHODS

136 splenic lesions (58 benign vascular neoplasms, 78 malignant) in 136 patients underwent baseline US and pulse-inversion CEUS after sulfur hexafluoride-filled microbubble injection. Two on-site readers assessed lesion enhancement features during arterial and parenchymal phase in consensus. Best predicting CEUS features for lesion diagnosis were identified through univariate and multivariate analyses. Two blinded off-site readers independently issued a confidence rating for lesion diagnosis in baseline US and CEUS using extracted diagnostic CEUS features. Diagnostic performance, receiver operating curves (Az-value), and interreader agreement were calculated. The reference standards were histopathology or CT and/or MR imaging with clinical follow-up. 

RESULTS

Multivariate analysis outlined arterial hyperenhancement or isoenhancement to be an independent CEUS predictor of benign vascular neoplasms (odds ratio, 3.558; p < 0.0017). Within the subgroup of isoechoic or hypoechoic lesions, arterial hyperenhancement was virtually diagnostic for benign vascular neoplasm (odds ratio, 21.333; p < 0.001). The diagnostic accuracy and confidence (Az-value) of the two readers was 63.2 % and 70.6 % (0.785 and 0.818) for baseline US, which improved significantly to 87.5 % and 88.2 % (0.915 and 0.908) for CEUS (p < 0.001). Interreader agreement also increased with CEUS (қ = 0.88) compared to baseline US (қ = 0.52).

CONCLUSION

Sulfur hexafluoride-enhanced CEUS improves differentiation between benign vascular and malignant splenic tumors and may be especially useful in clinical scenarios in which the incidental hypoechoic splenic lesion is unclear on conventional US.

Ultrasound-guided radiofrequency ablation: a new treatment option after failure to stop severe acute upper gastrointestinal tumor bleeding using endoscopic techniques

Endoscopy is well established as the primary approach in cases of severe acute upper gastrointestinal bleeding. Although endoscopic techniques can achieve hemostasis in up to 95% of instances, not all sources of bleeding seen at endoscopy can be managed endoscopically. Massive and diffuse bleeding from locally advanced gastric adenocarcinoma is not usually self-limit-ing and is often refractory to endoscopic treatment. If surgery or endovascular tumor embolization are not possible after failure of endoscopic hemostasis, the situation may become life-threaten-ing. We present a new option for the treatment of patients in this rare but potentially fatal situation, which involves radiofrequency ablation using a needle electrode placed percutaneously un-der ultrasound guidance.